Detalles de la búsqueda
1.
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).
Circulation
; 144(18): 1489-1499, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432985
2.
Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial.
Am Heart J
; 248: 35-41, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35263653
3.
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
Am Heart J
; 219: 47-57, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707324
4.
Associations between ß-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
Am Heart J
; 218: 92-99, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31715435
5.
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.
Diabetes Obes Metab
; 19(1): 78-86, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27607571
6.
Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial.
Clin Trials
; 13(2): 140-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26289822
7.
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
J Thromb Thrombolysis
; 42(3): 376-85, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324144
8.
Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial.
Eur Heart J
; 36(6): 385-92a, 2015 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012156
9.
The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study.
Am Heart J
; 169(2): 274-281.e1, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25641537
10.
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial.
Am Heart J
; 169(6): 890-898.e1, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26027628
11.
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes.
Am Heart J
; 168(2): 182-8.e1, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25066557
12.
An assessment of ST-segment measurement variability between two core electrocardiogram laboratories.
J Electrocardiol
; 47(1): 38-44, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246251
13.
Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction.
J Electrocardiol
; 47(4): 465-71, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24853083
14.
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times.
Circ Cardiovasc Interv
; 17(2): e013415, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38293830
15.
Relationship between baseline electrocardiographic measurements and outcomes in patients with high-risk heart failure: Insights from the VerICiguaT Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) trial.
Eur J Heart Fail
; 25(10): 1822-1830, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37655679
16.
Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.
JACC Heart Fail
; 11(9): 1246-1257, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37565973
17.
Evolution of NT-proBNP During Prerandomization Screening in VICTORIA: Implications for Clinical Outcomes and Efficacy of Vericiguat.
Circ Heart Fail
; 16(10): e010661, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503602
18.
Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy.
Eur J Heart Fail
; 25(7): 1012-1021, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36994634
19.
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA.
JACC Heart Fail
; 11(5): 583-592, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137660
20.
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.
JCI Insight
; 8(17)2023 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552540